Company: GEHC
Filing Date: 2025-10-29
Form Type: 10-Q
Source: 0001932393-25-000053
Chunk: 91

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-10-29
Form: 10-Q
Item: Item 8
Chunk 91
---
Cash flow hedges$32 $(43)$(29)$(13)Net investment hedges(1)(24)(116)(278)(57)(1) Amounts recognized in OCI for excluded components for the periods presented were immaterial.The tables below present the gains (losses) on our derivative financial instruments and hedging activity in the Condensed Consolidated Statements of Income.Derivative Financial Instruments and Hedging ActivityFor the three months ended September 30, 2025Cost of productsCost of servicesSG&AInterest and other financial charges – netOther(4)Foreign currency forward contracts$9 $2 $— $— $— Effects of cash flow hedges9 2 — — — Cross-currency swaps— — — 11 — Foreign currency forward and options contracts— — — 6 — Effects of net investment hedges(1)— — — 17 — Interest rate swaps(2)— — — 3 — Debt basis adjustment on Long-term borrowings— — — (7)— Effects of fair value hedges— — — (5)— Foreign currency forward contracts(11)(3)— — — Other derivatives(3)— — 4 — 12 Effects of derivatives not designated as hedging instruments(11)(3)4 — 12 For the three months ended September 30, 2024Cost of productsCost of servicesSG&AInterest and other financial charges – netOther(4)Foreign currency forward contracts$3 $1 $— $— $— Effects of cash flow hedges3 1 — — — Cross-currency swaps— — — 7 — Foreign currency forward and option contracts— — — 4 — Effects of net investment hedges(1)— — — 11 — Interest rate swaps(2)— — — 76 — Debt basis adjustment on Long-term borrowings— — — (84)— Effects of fair value hedges— — — (7)— Foreign currency forward contracts28 7 — — — Other derivatives(3)— — 2 — 5 Effects of derivatives not designated as hedging instruments28 7 2 — 5 

23

For